Transition Therapeutics Announces First Quarter Fiscal 2009 Financi...(- 1721873 Net loss and comprehens...),Health

Net loss and comprehensive loss

for the year - (16,119,202) (16,119,202)

-------------------------------------------------------------------------

Balance, June 30, 2008 3,093,735 (104,160,771) 63,687,755

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Stock options exercised or

cancelled (83,007) - 125,551

Stock-based compensation expense 643,548 - 643,548

Net loss and comprehensive loss

for the three-month period ended

September 30, 2008 - (5,032,796) (5,032,796)

-------------------------------------------------------------------------

Balance, September 30, 2008 3,654,276 (109,193,567) 59,424,058

-------------------------------------------------------------------------

-------------------------------------------------------------------------

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

Three-month Three-month

period ended period ended

September 30, September 30,

2008 2007

$ $

-------------------------------------------------------------------------

OPERATING ACTIVITIES

Net loss for the period (5,032,796) (4,098,978)

Add (deduct) items not involving cash:

Amortization of:

capital assets 48,853 59,204

intangible assets 784,894
'/>"/>